CMS SOM App. J, Tag W366

implementation, and review of each client's individual program plan either in person or

through written report to the interdisciplinary team.

Guidance §483.460(j)(5)

Pharmacist participation on the IDT is at the request of the team. It would not be necessary for

the pharmacist to routinely attend all team meetings when the client is on a stable drug regimen

that does not appear to be influencing his/her active treatment programs. Pharmacist

participation may be appropriate, in situations such as assisting the IDT develop the most

effective training programs for when the client is in an evolving situation with their medication.

For example:

• A client begins a new or more complex drug regimen;

• The physician orders off-label use of a medication;

• Frequent changes in the drug regimen are affecting IPP implementation.

(k) Standard: Drug administration